Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenues, net:    
Product $ 1,709,644 $ 2,165,500
Recurring 922,973 962,134
Total Net Revenues 2,632,617 3,127,634
Product 1,348,027 1,429,546
Recurring 254,302 266,163
Total Cost of Sales 1,602,329 1,695,709
Gross Profit 1,030,288 1,431,925
Operating Expenses:    
Research and development 296,690 302,142
Selling, general and administrative 1,382,719 1,460,593
Depreciation and amortization 66,661 64,118
Total Operating Expenses 1,746,070 1,826,853
Loss from Operations (715,782) (394,928)
Interest expense, net (11,114) (16,638)
Total Other Income (Expense) (11,114) (16,638)
Loss Before Provision for Income Taxes (726,896) (411,566)
Provision for Income Taxes 51,312 280
Net Loss (778,208) (411,846)
Accretion of preferred dividends and discount (35,761) (172,897)
Net loss attributable to common stockholders $ (813,969) $ (584,743)
Net income (loss) per common share:    
Income (loss) per common share - basic $ (0.01) $ 0.00
Income (loss) per common share - diluted $ (0.01) $ 0.00
Weighted Average Common Shares Outstanding - basic 125,035,612 108,103,001
Weighted Average Common Shares Outstanding - diluted 125,035,612 108,103,001